Novartis
Day 1 ASCO 2021 Roundup: Combating Lung Cancer, Hematologic Malignancies and Advanced Solid Tumors
2021-06-05
After Cardiovascular Disease, Novartis’ Rare Disease Drug Flops in Late-Stage Lung Cancer Study
2021-03-09
FDA Approval of Tepotinib Sets Stage for Merck Versus Novartis Showdown in Metastatic NSCLC Space
2021-02-05